Keywords: مهار کننده انتگرال; Indole; Antiviral activity; Entry and fusion inhibitor; Reverse transcriptase inhibitor; Integrase inhibitor; Protease inhibitor; Polymerase inhibitor; Natural product
مقالات ISI مهار کننده انتگرال (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen
Keywords: مهار کننده انتگرال; Residual viraemia; Elvitegravir/cobicistat; Dolutegravir; Non-nucleoside reverse transcriptase inhibitor; Integrase inhibitor; Protease inhibitor;
Influence of raltegravir intensification on viral load and 2-LTR dynamics in HIV patients on suppressive antiretroviral therapy
Keywords: مهار کننده انتگرال; Integrase inhibitor; Raltegravir; Treatment intensification; 2-LTR; Multi-stage models;
Les nouveaux médicaments en infectiologie
Keywords: مهار کننده انتگرال; antiviral d’action directe; association d’antirétroviraux; hépatite C; infectiologie; inhibiteur d’intégrase; sidaAIDS; antiretroviral combination therapy; direct-acting antiviral; hepatitis C; infectiology; integrase inhibitor
Raltegravir and elvitegravir-resistance mutation E92Q affects HLA-B*40:02-restricted HIV-1-specific CTL recognition
Keywords: مهار کننده انتگرال; Integrase inhibitor; CTL; HIV
Molecular dynamics study of carbon nanotube as a potential dual-functional inhibitor of HIV-1 integrase
Keywords: مهار کننده انتگرال; HIV-1 integrase; Integrase inhibitor; Carbon nanotube; Drug delivery; Molecular dynamics simulation;
Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors
Keywords: مهار کننده انتگرال; APC; Allophycocyanin fluorochrome; DMSO; Dimethylsulfoxide; FITC; Fluorescein isothiocyanate fluorochrome; HAART; Highly Active Antiretroviral Therapy; II; Integrase inhibitor; MFI; Median fluorescence intensity; MDR; Multi-drug resistance; NNRTI; Non-nuc
Structural modifications of 5,6-dihydroxypyrimidines with anti-HIV activity
Keywords: مهار کننده انتگرال; Dihydroxypyrimidine; Synthesis; HIV; Integrase inhibitor; Docking study;
Integrase-independent HIV-1 infection is augmented under conditions of DNA damage and produces a viral reservoir
Keywords: مهار کننده انتگرال; HIV-1; Integration; Integrase inhibitor; Provirus; HIV reservoir; DNA repair
In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4
Keywords: مهار کننده انتگرال; HIV; Integrase inhibitor; Resistance selection
A novel ultrasensitive LC-MS/MS assay for quantification of intracellular raltegravir in human cell extracts
Keywords: مهار کننده انتگرال; Raltegravir; Intracellular; HIV; LC-MS/MS; Integrase inhibitor;
Inhibition of Feline leukemia virus replication by the integrase inhibitor Raltegravir
Keywords: مهار کننده انتگرال; Integrase inhibitor; Feline leukemia virus; Antiretroviral therapy; Progressive infection; Raltegravir; Retrovirus
In-silico Comparative Study and Quantitative Structure-activity Relationship Analysis of Some Structural Physiochemical Descriptors of Elvitegravir Analogs
Keywords: مهار کننده انتگرال; Integrase inhibitor; multiple régression analysis; physiochemical descriptor; quantitative structure-activity relationship; structural descriptor;
Genetic variation of the HIV-1 integrase region in newly diagnosed anti-retroviral drug-naïve patients with HIV/AIDS in Korea
Keywords: مهار کننده انتگرال; Genetic variation; HIV-1; integrase inhibitor; polymorphism; resistant mutation
Synthesis and biological evaluation of HQCAs with aryl or benzyl substituents on N-1 position as potential HIV-1 integrase inhibitors
Keywords: مهار کننده انتگرال; HIV; Integrase inhibitor; Quinolone-3-carboxylic acids; Two-metal chelating mechanism; Structure-activity relationships;
Structural modifications of quinolone-3-carboxylic acids with anti-HIV activity
Keywords: مهار کننده انتگرال; HIV; Integrase inhibitor; Quinolone-3-carboxylic acids; Two-metal chelating mechanism;
Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5
Keywords: مهار کننده انتگرال; Caffeoyl-anilide; Anti-HIV; Integrase inhibitor; CCR5 inhibitor; Portmanteau inhibitor
Quantifying the HIV-1 integrase inhibitor raltegravir in female genital tract secretions using high-performance liquid chromatography with ultraviolet detection
Keywords: مهار کننده انتگرال; Raltegravir; Integrase inhibitor; Female genital tract; Cervicovaginal fluid; Solid-phase extraction; High-performance liquid chromatography
Drugs for HIV: strategies for use
Keywords: مهار کننده انتگرال; antiretroviral; CCR5 antagonist; HIV; integrase inhibitor; nucleoside reverse transcriptase inhibitor (NRTI); non-nucleoside reverse transcriptase inhibitor (NNRTI); protease inhibitor
Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics
Keywords: مهار کننده انتگرال; S/GSK-364735; S-1360; Integrase inhibitor; HIV; Resistance
Tricyclic HIV integrase inhibitors: Potent and orally bioavailable C5-aza analogs
Keywords: مهار کننده انتگرال; AIDS; HIV; Integrase inhibitor; Tricyclic
Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors
Keywords: مهار کننده انتگرال; HIV-1; Integrase inhibitor; Antiviral
A sensitive HPLC–MS–MS method for the determination of raltegravir in human plasma
Keywords: مهار کننده انتگرال; HIV; Integrase inhibitor; Mass spectrometry; Human; Raltegravir
Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants
Keywords: مهار کننده انتگرال; S/GSK-364735; S-1360; Integrase inhibitor; HIV; Resistance
An accurate and precise high-performance liquid chromatography method for the rapid quantification of the novel HIV integrase inhibitor raltegravir in human blood plasma after solid phase extraction
Keywords: مهار کننده انتگرال; Raltegravir; Integrase inhibitor; Human immunodeficiency virus; Antiretroviral agent; High-performance liquid chromatography-UV; Solid phase extraction; Chromatography;
Synthesis of a hexahydropyrimido[1,2-a]azepine-2-carboxamide derivative useful as an HIV integrase inhibitor
Keywords: مهار کننده انتگرال; Hexahydropyrimido[1,2-a]azepine; Integrase inhibitor; 1,2,4-Oxadiazoline; Amidoxime;
The synthesis of tetrahydropyridopyrimidones as a new scaffold for HIV-1 integrase inhibitors
Keywords: مهار کننده انتگرال; Tetrahydropyridopyrimidone; Integrase inhibitor; 1,2,4-Oxadiazoline; Amidoxime;
Integrase inhibitors as a new class of ARV treatment
Keywords: مهار کننده انتگرال; HIV replication; integrase; integrase inhibitor; ARV treatment; multidrug resistance;
8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors
Keywords: مهار کننده انتگرال; HIV; Integrase inhibitor; Antiviral
Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of l-chicoric acid, as new HIV-1 integrase inhibitors
Keywords: مهار کننده انتگرال; Human immunodeficiency virus; Integrase inhibitor; l-Chicoric acid; Caffeoylglycolic acid; Caffeoylamino acid
Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid–liquid extraction and HPLC-MS/MS
Keywords: مهار کننده انتگرال; Integrase inhibitor; Raltegravir; MK-0518; Plasma; Bioanalytical; HPLC–MS/MS; Liquid–liquid extraction